Last week, the Food and Drug Administration (FDA) authorized the emergency use of a new COVID-19 vaccine developed by Johnson & Johnson (J&J) and Janssen Pharmaceutical Companies. Although there currently are two COVID-19 vaccines being administered, the introduction of this third option is significant in the battle against this deadly virus, given that it only requires a single dose and can be safely stored in less restrictive refrigerated environments.
Today, we are excited to announce that Texas Children’s has been informed that we will be receiving an allocation of 3,000 doses of the J&J vaccine to provide our patients and team members next week. We are currently awaiting confirmation from the State on the specific date these vaccines will arrive and will provide all unvaccinated team members with more information on administration appointments next week.
These are the only vaccines provided by the State that will be available next week. With the recent mask mandate scheduled to end in Texas on Wednesday, please take this important opportunity to get vaccinated and further protect yourself, your family, colleagues and our patients from this deadly virus.
If you have questions about the J&J vaccine, below are some general facts. Additional information is also available through the FDA, as well as via a recent blog from Texas Children’s.
J&J Vaccine: What you should know
The J&J vaccine currently only requires one dose and is approved for people ages 18 and older.
During global trials, it was shown to be (on average) 66% protective against moderate to severe COVID-19 infections from 28 days after injection. In the U.S., the vaccine was 72% protective. The vaccine was also shown to be 85% protective against severe disease and prevented death in all vaccine recipients.
The vaccine is different from those produced by Pfizer and Moderna, which both use messenger RNA, or mRNA, a technology that delivers a bit of “genetic code” to cells to produce a surface spike protein and trigger an immunity response to COVID-19. The J&J vaccine utilizes a weakened common cold virus, known as adenovirus, to carry genetic instructions into the body to prompt an immunity response. This is the same technology used in an approved Ebola vaccine, as well as its Zika, RSV and HIV vaccine candidates.
Similar to the current authorized COVID-19 vaccines, the J&J vaccine can be administered to pregnant and breastfeeding women.
The J&J vaccine does not need to be kept frozen and can be stored in a refrigerator for at least three months, which potentially increases global distribution and access to more communities.
Questions?
For more information, visit our website. You may also contact our HR Employee Support Center at 832-826-4600 from 8 a.m. to 5 p.m., Monday through Friday, or email employeevaccines@texaschildrens.org.